Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brunello

Showing results (691-700 of 728) with videos related to

Pageof 73
Sort By:
Breast Cancer Research and Treatment|February 12, 2022
Systemic treatment in advanced phyllodes tumor of the breast: a multi-institutional European retrospective case-series analysesE Palassini, O Mir, G Grignani, et al.
Nature Communications|November 25, 2024
Critical assessment of LC3/GABARAP ligands used for degrader development and ligandability of LC3/GABARAP binding pocketsMartin P Schwalm, Johannes Dopfer, Adarsh Kumar, et al.
JAMA Network Open|November 6, 2023
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence: A Report From the Italian Sarcoma GroupLorenzo D'Ambrosio, Elena Fumagalli, Tommaso Martino De Pas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2024
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.
ESMO Open|March 8, 2025
Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trialA Vanzulli, R Vigorito, C Buonomenna, et al.
Cell|February 19, 2021
Antidepressant drugs act by directly binding to TRKB neurotrophin receptorsPlinio C Casarotto, Mykhailo Girych, Senem M Fred, et al.
Transplantation and Cellular Therapy|January 27, 2025
Prospective Validation of CAR-HEMATOTOX and a Simplified Version Predict Survival in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 CAR T-Cells: Data from CART-SIE StudyFederico Stella, Martina Pennisi, Annalisa Chiappella, et al.
Transplantation and Cellular Therapy|February 25, 2026
Systemic inflammation and CAR-T specific toxicities as major drivers of non-relapse mortality: analysis from the Italian prospective observational CART-SIE StudyAngelica Barone, Federico Stella, Silva Ljevar, et al.
Blood Advances|August 20, 2020
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-CyJacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
JAMA Network Open|November 6, 2025
Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas: A Secondary Analysis of a Randomized Clinical TrialSandro Pasquali, Paola Collini, Cleofe Romagosa, et al.
Pageof 73

Showing results (691-700 of 728) with videos related to

Sort By:
Pageof 73
Breast Cancer Research and Treatment|February 12, 2022
Systemic treatment in advanced phyllodes tumor of the breast: a multi-institutional European retrospective case-series analysesE Palassini, O Mir, G Grignani, et al.
Nature Communications|November 25, 2024
Critical assessment of LC3/GABARAP ligands used for degrader development and ligandability of LC3/GABARAP binding pocketsMartin P Schwalm, Johannes Dopfer, Adarsh Kumar, et al.
JAMA Network Open|November 6, 2023
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence: A Report From the Italian Sarcoma GroupLorenzo D'Ambrosio, Elena Fumagalli, Tommaso Martino De Pas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2024
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.
ESMO Open|March 8, 2025
Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trialA Vanzulli, R Vigorito, C Buonomenna, et al.
Cell|February 19, 2021
Antidepressant drugs act by directly binding to TRKB neurotrophin receptorsPlinio C Casarotto, Mykhailo Girych, Senem M Fred, et al.
Transplantation and Cellular Therapy|January 27, 2025
Prospective Validation of CAR-HEMATOTOX and a Simplified Version Predict Survival in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 CAR T-Cells: Data from CART-SIE StudyFederico Stella, Martina Pennisi, Annalisa Chiappella, et al.
Transplantation and Cellular Therapy|February 25, 2026
Systemic inflammation and CAR-T specific toxicities as major drivers of non-relapse mortality: analysis from the Italian prospective observational CART-SIE StudyAngelica Barone, Federico Stella, Silva Ljevar, et al.
Blood Advances|August 20, 2020
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-CyJacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
JAMA Network Open|November 6, 2025
Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas: A Secondary Analysis of a Randomized Clinical TrialSandro Pasquali, Paola Collini, Cleofe Romagosa, et al.
Pageof 73